Interpretation of the NCCN clinical practice guidelines in oncology for non-small cell lung cancer (version 2.2023) / 中国胸心血管外科临床杂志
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
; (12): 660-664, 2023.
Article
en Zh
| WPRIM
| ID: wpr-996477
Biblioteca responsable:
WPRO
ABSTRACT
@#Lung cancer is the malignancy with the highest incidence and mortality rate in China. In recent years, the popular use of low-dose computed tomography in the population has led to an increase in the detection rate of pulmonary nodules. The National Comprehensive Cancer Network (NCCN) updated and released the NCCN clinical practice guidelines in oncology for non-small cell lung cancer (version 2.2023) on February 17, 2023. This article will interpret the main updates of the new guideline and compare it with the domestic lung cancer treatment guidelines, providing new ideas for the diagnosis and treatment of lung cancer for Chinese clinicians.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
Año:
2023
Tipo del documento:
Article